Prognostic Factors Affecting Management of Liposarcoma

§ Saint Anns Bay Regional Hospital, Saint Ann, Saint Anns Bay Regional Hospital, Saint Ann,

Send Message

To: Author

Prognostic Factors Affecting Management of Liposarcoma

Article Fingerprint

ReserarchID

MR3M47H

Prognostic Factors Affecting Management of Liposarcoma Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background
This converted HTML version may contain rendering inconsistencies. Please refer to the PDF for the authoritative version, or click here to provide feedback.

Abstract

Soft tissue sarcomas account for 1% of all neoplasms, with the second commonest being liposarcomas. Liposarcomas in the popliteal fossa often grows to a large size, as neither the patient nor the clinician will initially be able to palpate the tumour due to its depth in the tissues and the fact that the tumour is often low grade. Its size often does not facilitate the ability to resect the mass with wide margins. The following article discusses prognostic factors for liposarcomas with regards to histological subtype, anatomical distribution, resection margins and neoadjuvant therapy.

References

40 Cites in Article
  1. 1. C Fletcher,K Umi,F Mertens (2002). World Health Organisation classification of tumours pathology and genetics of tumours of soft tissue and bone. IARC Press, 35-46.
  2. 2. A Jemal,R Siegel,E Ward,Y Hao,J Xu,T Murray,M Thun (2008). Cancer Statistics, 2008. CA: A Cancer Journal for Clinicians, 58(2), 71-96.
  3. 3. Hyo Kim,Jeeyun Lee,Seong Yi,Hyun Jun,Yoon-La Choi,Geung Ahn,Sung Seo,Do Lim,Yong Ahn,Joon Park,Sung Kim (2009). Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy. BMC Cancer, 9(1), 205.
  4. 4. A Leow,A Halim,Z Win (2005). Reconstructive treatment following resection of high-grade soft-tissue sarcomas of the lower limb. J Orth Surg, 13(1), 58-63.
  5. 5. N Gilbert,C Cannon,P Lin,O Valerae (2009). Soft tissue sarcoma. J Am Acad Orthop Surg, 17(1), 40-47.
  6. 6. W Mendenhall,D Indelicato,M Scarborough,R Zlotecki,C Gibbs,N Mendenhall (2009). The management of adult soft tissue sarcomas. Am J Clin Oncol, 32(4), 436-442.
  7. 7. Franklin Sim,Frank Frassica,Deborah Frassica (1994). Soft-Tissue Tumors: Diagnosis, Evaluation, and Management. Journal of the American Academy of Orthopaedic Surgeons, 2(4), 202-211.
  8. 8. C Chandrasekar,H Wafa,R Grimer,S Cater,R Tillman,A Abudu (2008). The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br, 90(2), 203-208.
  9. 9. Jonathan Lewis,Murray Brennan (1996). Soft tissue sarcomas. Current Problems in Surgery, 33(10), 820-872.
  10. 10. J Peterson,M Kransdorf,L Bancroft,M O'connor (2003). malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol, 32(9), 493-503.
  11. 11. F Enzinger,S Weiss,Liposarcoma,S Weiss,J Goldblum,F Enzinger,Enzinger,Weiss (1995). s Soft Tissue Tumors. s Soft Tissue Tumors, 821-828.
  12. 12. David Linehan,Jonathan Lewis,Denis Leung,Murray Brennan (2000). Influence of Biologic Factors and Anatomic Site in Completely Resected Liposarcoma. Journal of Clinical Oncology, 18(8), 1637-1643.
  13. 13. Dempsey Springfield (1993). Liposarcoma. Clinical Orthopaedics and Related Research, 289, 50???57.
  14. 14. Y Ng,M Tan (2009). Liposarcoma of the extremities: a review of the cases seen and managed in a major tertiary hospital in Singapore. Singapore Med J, 50(9), 857-861.
  15. 15. D Lucas,A Nascimento,B Sanjay,M Rock (1994). Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol, 102(5), 677-683.
  16. 16. S Weiss,V Rao (1992). Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation. Am J Surg Pathol, 16(11), 1051-1058.
  17. 17. S Lietman,W Barsoum,J Goldblum,K Marks,E Mascha,M Sundaram (2007). A 20-Year Retrospective Review of Surgically Treated Liposarcoma at the Cleveland Clinic. Orthopedics, 30(3), 227-234.
  18. 18. Andrea Ferrari,Michela Casanova,Filippo Spreafico,Roberto Luksch,Monica Terenziani,Graziella Cefalo,Maura Massimino,Lorenza Gandola,Piera Navarria,Franca Fossati-Bellani (1999). CHILDHOOD LIPOSARCOMA: A Single-Institutional Twenty-Year Experience. Pediatric Hematology and Oncology, 16(5), 415-421.
  19. 19. P Gustafson,A Rydholm,H Willen,B Baldetorp,M Ferno,M Akerman (1993). Liposarcoma: a population based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content. Int J Cancer, 55, 541-546.
  20. 20. P Reszel,E Soule,M Coventry (1966). Liposarcoma of the extremities and limb girdles. A study of two hundred twenty-two cases. J Bone Joint Surg Am, 48(2), 229-244.
  21. 21. Hans-Ulrich Steinau,Adrien Daigeler,Stefan Langer,Lars Steinsträsser,Jörg Hauser,Ole Goertz,Markus Lehnhardt (2010). Limb Salvage in Malignant Tumors. Seminars in Plastic Surgery, 24(01), 018-033.
  22. 22. Edward Cheng,Dempsey Springfield,Henry Mankin (1995). Frequent incidence of extrapulmonary sites of initial metastasis in patients with liposarcoma. Cancer, 75(5), 1120-1127.
  23. 23. K Dalal,M Kattan,C Antonescu,M Brennan,S Singer (2006). Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg, 244(3), 381-391.
  24. 24. Gunar Zagars,Mary Goswitz,Alan Pollack (1996). Liposarcoma: Outcome and prognostic factors following conservation surgery and radiation therapy. International Journal of Radiation Oncology*Biology*Physics, 36(2), 311-319.
  25. 25. D Mccormick,T Mentzel,A Beham,C Fletcher (1994). Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol, 18(12), 1213-1223.
  26. 26. Helena Chang,Steven Hajdu,Charles Collin,Murray Brennan (1989). The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer, 64(7), 1514-1520.
  27. 27. T Mentzel,C Fletcher (1997). Dedifferentiated myxoid liposarcoma: a clinicopathological study suggesting a closer relationship between myxoid and well‐differentiated liposarcoma. Histopathology, 30(5), 457-463.
  28. 28. J Wu,E Montgomery (2008). Classification and pathology. Surg Clin North Am, 88(3), 483-484.
  29. 29. Tamara Smith,Kirk Easley,John Goldblum (1996). Myxoid/Round Cell Liposarcoma of the Extremities. The American Journal of Surgical Pathology, 20(2), 171-180.
  30. 30. David Pearlstone,Peter Pisters,Richard Bold,Barry Feig,Kelly Hunt,Alan Yasko,Shreyaskumar Patel,Alan Pollack,Robert Benjamin,Raphael Pollock (1999). Patterns of recurrence in extremity liposarcoma. Cancer, 85(1), 85-92.
  31. 31. G Orson,F Sim,H Reiman,W Taylor (1987). Liposarcoma of the musculoskeletal system. Cancer, 15(6), 1362-1370.
  32. 32. R De Vreeze,D De Jong,P Nederlof,A Ariaens,I Tielen,L Frenken (2010). Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience. Ann Surg Oncol, 17(3), 686-693.
  33. 33. O Berlin,B Stener,L Angerval,L-G Kindblom,G Markhede,A Oden (1990). Surgery for soft tissue sarcoma in the extremities. A multivariate analysis of the 6-26-year prognosis in 137 patients. Acta Ortho Scand, 61(6), 475-523.
  34. 34. Matthew Hueman,Katherine Thornton,Joseph Herman,Nita Ahuja (2008). Management of Extremity Soft Tissue Sarcomas. Surgical Clinics of North America, 88(3), 539-557.
  35. 35. A Kaushal,D Citrin (2008). The role of radiation therapy in the management of sarcomas. Surg Clin North Am, 88(3), 629-646.
  36. 36. Corinne Sadoski,Herman Suit,Andrew Rosenberg,Henry Mankin,Jimmy Efird (1993). Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. Journal of Surgical Oncology, 52(4), 223-230.
  37. 37. E Baldini,J Goldberg,C Jenner,J Manola,G Demetri,C Fletcher (1999). Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol, 17(10), 3252-3259.
  38. 38. Diego Ribuffo,Maria Giuseppina Onesti,Emilia Elia,Vittorio Cucchiara,Maurizio Valeriani,Nicolò Scuderi (1998). CONTROVERSIAL ISSUES IN DIAGNOSIS OF LIPOSARCOMAS OF THE THIGH: A report of 18 cases. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 32(3), 323-330.
  39. 39. Fritz Eilber,Frederick Eilber,Jeffery Eckardt,Gerald Rosen,Elyn Riedel,Robert Maki,Murray Brennan,Samuel Singer (2004). The Impact of Chemotherapy on the Survival of Patients With High-grade Primary Extremity Liposarcoma. Annals of Surgery, 240(4), 686-697.
  40. 40. C Knebel,U Lenze,F Pohlig,F Lenze,N Harrasser,C Suren,H Mühlhofer (2017). Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years. BMC Cancer, 17, 410.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Cary Fletcher. 2018. "Prognostic Factors Affecting Management of Liposarcoma". Global Journal of Medical Research - H: Orthopedic & Musculoskeletal System GJMR-H Volume 17 (GJMR Volume 17 Issue H1).

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmr

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-H Classification NLMC Code: WE 168
Version of record

v1.2

Issue date
January 24, 2018

Language
English
Order Article Reprint
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 1.6K
Total Downloads: 150
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Prognostic Factors Affecting Management of Liposarcoma

Cary Fletcher
Cary Fletcher Saint Anns Bay Regional Hospital, Saint Ann,